NEXGEL and STADA Partner to Launch Histasolv in North America
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced the distribution of Histasolv®, a leading product targeting histamine food intolerance, under its new partnership with STADA Arzneimittel AG. This marks …
NEXGEL and STADA Partner to Launch Histasolv in North America Read More